谭智军;赵玉国;肖晓艳;

• 1:郴州市第一人民医院

摘要(Abstract)：

目的观察结肠癌组织中长链非编码RNA(lncRNA)母源性表达基因8(MEG8)、转谷氨酰胺酶2(TGM2)mRNA的表达变化,并探讨其意义。方法采用实时荧光定量PCR法检测85例份结肠癌组织及其癌旁正常组织MEG8、TGM2 mRNA,分析两者间及其与结肠癌临床病理参数、患者预后的关系。结果结肠癌及其癌旁正常组织MEG8 mRNA相对表达量分别为0.62±0.23、1.87±0.55,TGM2 mRNA相对表达量分别为2.03±0.95、0.98±0.36,两者比较,P均<0.05。MEG8、TGM2 mRNA表达均与结肠癌TNM分期、淋巴结转移有关(P均<0.05)。结肠癌组织中MEG8 mRNA和TGM2 mRNA表达呈显著负相关(r=-0.798,P<0.05)。MEG8 mRNA高表达者5年总生存率为77.78%(35/45)、生存时间为(43.62±8.31)个月,低表达者分别为52.50%(21/40)、(31.07±7.25)个月,两者比较,P均<0.05;TGM2 mRNA高表达者5年总生存率为54.55%(24/44)、生存时间为(37.21±9.68)个月,低表达者分别为78.49%(32/41)、(49.18±8.76)个月,两者比较,P均<0.05。结肠癌患者预后Cox回归模型分析显示,高级别TNM分期、有淋巴结转移、MEG8 mRNA低表达、TGM2 mRNA高表达是影响结肠癌患者预后的危险因素(P均<0.05)。结论结肠癌组织中MEG8 mRNA呈低表达,TGM2 mRNA呈高表达,两者表达均与TNM分期、淋巴结转移有关,检测两指标有助于评估疾病病情及患者预后。

关键词(KeyWords)： 结肠癌;结肠肿瘤;母源性表达基因8;转谷氨酰胺酶2

Abstract:

Keywords:

基金项目(Foundation): 湖南省科技计划项目(2016JJ0128)

作者(Author): 谭智军;赵玉国;肖晓艳;

Email:

DOI:

参考文献(References)：

• [1] 贾俊婷,柴丽敏,郝志英.重组高密度脂蛋白—紫杉醇对结肠癌的靶向性研究[J].中国医院药学杂志,2019,39(2):161-164.
• [2] BEYGO J,KüCHLER A,GILLESSEN-KAESBACH G,et al.New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome[J].Eur J Hum Genet,2017,25(8):935-945.
• [3] TERASHIMA M,ISHIMURA A,WANNA-UDOM S,et al.MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells[J].J Biol Chem,2018,293(47):18016-18030.
• [4] 雷志杰,张莹,田苗苗,等.TGM2对胃癌细胞BGC-823增殖、迁移和侵袭能力的影响[J].现代生物医学进展,2018,18(10):1816-1822.
• [5] 贺文兴,黄传生,全军利,等.组织型转谷氨酰胺酶对乳腺癌侵袭转移作用的研究[J].中华肿瘤防治杂志,2015,22(12):936-940.
• [6] 王玉萍,张娟.组织转谷氨酰胺酶2对乙型肝炎相关性肝细胞癌进展的影响[J].中国老年学杂志,2018,38(20):4999-5001.
• [7] BOSMAN F T,CAMEIRO F,HRUBAN R H,et al.World health organization classification of tumours of the digestive system[M].Lyon:IARC Press,2010:195-234.
• [8] 李景林,李正龙,黄立宁,等.结肠癌相关转录子2的调控机制及与消化系统肿瘤关系的研究进展[J].中国医师杂志,2018,20(5):790-793.
• [9] CHEN T,LIN H,CHEN X,et al.LncRNA Meg8 suppresses activation of hepatic stellate cells and epithelial-mesenchymal transition of hepatocytes via the Notch pathway[J].Biochem Biophys Res Commun,2020,521(4):921-927.
• [10] 刘锋瑞,刘亚娟,高红艳,等.丝氨酸羟甲基转移酶2(SHMT2)调控AMPK/mTOR通路诱导自噬促进结肠癌细胞化疗耐药[J].细胞与分子免疫学杂志,2019,35(4):344-350,356.
• [11] ZHANG B,DONG Y,ZHAO Z.LncRNA MEG8 regulates vascular smooth muscle cell proliferation,migration and apoptosis by targeting PPARα[J].Biochem Biophys Res Commun,2019,510(1):171-176.
• [12] ZHANG M,ZHAO Y,WANG G,et al.An imprinted long noncoding RNA located between genes Meg8 and Meg9 in the cattle Dlk1-Dio3 domain[J].Genetica,2017,145(1):1-7.
• [13] BENS S,KOLAROVA J,GILLESSEN-KAESBACH G,et al.The differentially methylated region of MEG8 is hypermethylated in patients with temple syndrome[J].Epigenomics,2015,7(7):1089-1097.
• [14] LUDVIGSEN T P,OLSEN L H,PEDERSEN H D,et al.Hyperglycemia-induced transcriptional regulation of ROCK1 and TGM2 expression is involved in small artery remodeling in obese diabetic Gottingen Minipigs[J].Clin Sci (Lond),2019,133(24):2499-2516.
• [15] WANG X,YU Z,ZHOU Q,et al.Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway[J].Oncotarget,2016,7(6):7066-7079.
• [16] GU C,CAI J,XU Z,et al.MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling[J].Cell Death Dis,2019,10(10):739.
• [17] MIYOSHI N,ISHII H,MIMORI K,et al.TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer[J].Ann Surg Oncol,2010,17(4):967-972.
• [18] DELBRIDGE A R,GRABOW S,STRASSER A,et al.Thirty years of BCL-2:translating cell death discoveries into novel cancer therapies [J].Nat Rev Cancer,2016,16(2):99-109.
• [19] YANG P,YU D,ZHOU J,et al.TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway[J].Cell Cycle,2019,18(10):1122-1134.
• [20] HE W,SUN Z,LIU Z.Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel[J].Exp Ther Med,2015,10(4):1413-1418.
• [21] FRANZESE O,MINOTTI L,AGUIARI G,et al.Involvement of non-coding RNAs and transcription factors in the induction of transglutaminase isoforms by ATRA[J].Amino Acids,2019,51(9):1273-1288.